BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 18779762)

  • 1. Patterns and determinants of patient-delivered therapy uptake among healthcare consumers.
    Goldsworthy RC; Fortenberry DJ
    Sex Transm Dis; 2009 Jan; 36(1):25-32. PubMed ID: 18779762
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Formative design and evaluation of patient-delivered partner therapy informational materials and packaging.
    McBride K; Goldsworthy RC; Fortenberry JD
    Sex Transm Infect; 2009 Apr; 85(2):150-5. PubMed ID: 19103640
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alternative approaches to partner notification, diagnosis, and treatment: pharmacists' perspectives on proposed patient delivered partner therapy in New York State, 2007.
    McNutt LA; Davis CF; Bednarczyk RA; Fischer A; Zeolla M; Coles BF
    Sex Transm Dis; 2009 Mar; 36(3):178-84. PubMed ID: 19174732
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Patient-delivered partner therapy for chlamydial infections: attitudes and practices of California physicians and nurse practitioners.
    Packel LJ; Guerry S; Bauer HM; Rhew M; Chow J; Samuel M; Bolan G
    Sex Transm Dis; 2006 Jul; 33(7):458-63. PubMed ID: 16794548
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Patient-delivered partner therapy for chlamydial infections: practices, attitudes, and knowledge of california family planning providers.
    Jotblad S; Park IU; Bauer HM; Barandas A; Deal M; Amey A
    Sex Transm Dis; 2012 Feb; 39(2):122-7. PubMed ID: 22249301
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Patient-delivered partner treatment for male urethritis: a randomized, controlled trial.
    Kissinger P; Mohammed H; Richardson-Alston G; Leichliter JS; Taylor SN; Martin DH; Farley TA
    Clin Infect Dis; 2005 Sep; 41(5):623-9. PubMed ID: 16080084
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Patient-delivered partner treatment and other partner management strategies for sexually transmitted diseases used by New York City healthcare providers.
    Rogers ME; Opdyke KM; Blank S; Schillinger JA
    Sex Transm Dis; 2007 Feb; 34(2):88-92. PubMed ID: 16810120
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Physicians' opinions on partner management for nonviral sexually transmitted infections.
    Niccolai LM; Winston DM
    Am J Prev Med; 2005 Feb; 28(2):229-33. PubMed ID: 15710281
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alternative approaches to partner notification, diagnosis, and treatment: perspectives of New York County Health Departments, 2007.
    Davis CF; Cummings M; Coles BF; McNutt LA
    Sex Transm Dis; 2009 Mar; 36(3):185-90. PubMed ID: 19174730
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Concurrent sexually transmitted infections (STIs) in sex partners of patients with selected STIs: implications for patient-delivered partner therapy.
    Stekler J; Bachmann L; Brotman RM; Erbelding EJ; Lloyd LV; Rietmeijer CA; Handsfield HH; Holmes KK; Golden MR
    Clin Infect Dis; 2005 Mar; 40(6):787-93. PubMed ID: 15736009
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High willingness to use novel HIV and bacterial sexually transmitted infection partner notification, testing, and treatment strategies among gay and bisexual men.
    John SA; Starks TJ; Rendina HJ; Parsons JT; Grov C
    Sex Transm Infect; 2020 May; 96(3):173-176. PubMed ID: 31189548
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Public attitudes regarding willingness to participate in medical research studies.
    Trauth JM; Musa D; Siminoff L; Jewell IK; Ricci E
    J Health Soc Policy; 2000; 12(2):23-43. PubMed ID: 11184441
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Patient and partner perspectives on patient-delivered partner screening: acceptability, benefits, and barriers.
    McBride KR; Goldsworthy RC; Fortenberry JD
    AIDS Patient Care STDS; 2010 Oct; 24(10):631-7. PubMed ID: 20863245
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel interventions to reduce re-infection in women with chlamydia: a randomized controlled trial.
    Cameron ST; Glasier A; Scott G; Young H; Melvin L; Johnstone A; Elton R
    Hum Reprod; 2009 Apr; 24(4):888-95. PubMed ID: 19136481
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Testing the Interpersonal-Behavior model to explain intentions to use patient-delivered partner therapy.
    John SA; Walsh JL; Quinn KG; Cho YI; Weinhardt LS
    PLoS One; 2020; 15(5):e0233348. PubMed ID: 32433680
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Public stigma in health and non-healthcare students: attributions, emotions and willingness to help with adolescent self-harm.
    Law GU; Rostill-Brookes H; Goodman D
    Int J Nurs Stud; 2009 Jan; 46(1):107-18. PubMed ID: 18962601
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 'It's literally giving them a solution in their hands': the views of young Australians towards patient-delivered partner therapy for treating chlamydia.
    Layton E; Goller JL; Coombe J; Temple-Smith M; Tomnay J; Vaisey A; Hocking JS
    Sex Transm Infect; 2021 Jun; 97(4):256-260. PubMed ID: 33441448
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human papillomavirus vaccine acceptability among young adult men.
    Gerend MA; Barley J
    Sex Transm Dis; 2009 Jan; 36(1):58-62. PubMed ID: 18830138
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Receptiveness to Patient-Delivered Partner Therapy (PDPT) for Chlamydia Infection: Exploratory Findings From a Sample of Canadian Youth.
    Vandermorris A; Kerr L; Kives S
    J Obstet Gynaecol Can; 2019 Apr; 41(4):473-478. PubMed ID: 30528443
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Considering the patient in patient-delivered partner therapy.
    Kissinger P
    Sex Transm Infect; 2009 Apr; 85(2):80-1. PubMed ID: 19307352
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.